As per MRFR analysis, the India Human Genetics Market Size was estimated at 1.15 (USD Billion) in 2023.The India Human Genetics Market is expected to grow from 1.27(USD Billion) in 2024 to 4.12 (USD Billion) by 2035. The India Human Genetics Market CAGR (growth rate) is expected to be around 11.289% during the forecast period (2025 - 2035).
Biotechnology breakthroughs and a greater focus on individualized care are driving major changes in the Indian human genetics market at the moment. Understanding and using genetic information for diagnoses and cures is becoming more popular among patients and healthcare professionals as the industry shifts to more individualized treatments.
Innovation in this field is being strongly supported by government programs designed to advance genomes and biotechnology research. India's capabilities in human genetics are further enhanced by the creation of genomic research centers and partnerships with foreign institutions.
The growing need for genetic testing and customized treatments among Indians presents opportunities to enter this market. People are becoming more aware of hereditary disorders and the advantages of preventive genetic screening, which motivates them to use these services.
Additionally, the growing pharmaceutical sector is spending more money on genetic research, which is accelerating the creation of specialized therapies based on genetic profiles. Recent trends show a significant rise in partnerships between academic institutions and biotech firms to take advantage of genomics research.
A culture of innovation is being fostered by this dynamic, with an emphasis on creating affordable genetic testing options. Additionally, the market is being revolutionized by the growing use of machine learning and artificial intelligence in genetic analysis, which produces faster and more accurate results.
All things considered, the Indian human genetics market is expected to expand thanks to government programs, rising consumer awareness, and new technical developments.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Increasing Prevalence of Genetic Disorders
The rising incidence of genetic disorders in India is a significant driver for the India Human Genetics Market. According to a report from the Ministry of Health and Family Welfare, approximately 1 in 10,000 individuals in India is born with a genetic disorder.
This statistic indicates a substantial population that may require genetic testing and therapies. Major organizations such as the Indian Council of Medical Research are actively funding research initiatives and awareness campaigns, leading to increased demand for genetic testing services.
Furthermore, as the awareness surrounding genetic disorders grows and screening becomes more accessible, it is likely that a larger segment of the population will seek these services, significantly bolstering the market's growth and future prospects.
Advancements in Genetic Research and Technology
Technological advancements in genetic research and development significantly fuel the growth of the India Human Genetics Market. The Government of India's push for Research and Development in biotechnology has led to the establishment of new laboratories and research facilities.
For instance, the Department of Biotechnology has undertaken initiatives to support innovative approaches such as next-generation sequencing technology, which has seen an increase in funding allocation of over 25% in recent years.
This enhanced capacity for genetic analysis and testing is crucial for effective disease management, and as technology continues to evolve, the market is expected to expand rapidly.
Growing Demand for Personalized Medicine
The shift towards personalized medicine in India presents another vital driver for the India Human Genetics Market. According to the National Health Policy of 2017, there is a growing acknowledgment of the need for tailored medical treatments that address individual genetic profiles.
This trend toward personalized healthcare is powered by both healthcare providers and patients. For instance, established biotechnology firms in India, such as Biocon and Dr. Reddy's Laboratories, are investing heavily in genomics and individualized treatment regimens.
As patients become more informed and seek therapies that consider their unique genetic makeup, the demand for genetic testing and analysis services will rise, propelling the market growth.
The Application segment within the India Human Genetics Market has seen notable growth due to increasing awareness of personalized healthcare and advancements in genetic research. The significance of this segment can be largely attributed to its diverse range of applications, particularly in areas like Wellness and E-Commerce, Preventive Medicine, and Diagnostic and Treatment.
In the realm of Wellness and E-Commerce, there has been a surge in genetic testing products that cater to health enthusiasts looking for personalized solutions. The rise of digital platforms has facilitated the accessibility of genetic testing services, allowing individuals to gain insights into their health and wellness, thereby promoting preventive measures.
On the other hand, Preventive Medicine is becoming increasingly critical, with genetic screenings expected to play a pivotal role in identifying predispositions to various diseases, allowing for early intervention strategies.
Governments are investing in preventive healthcare initiatives which not only aim to reduce healthcare costs but also focus on enhancing the population's overall health standards. Moreover, the Diagnostic and Treatment aspect of the Application segment is gaining traction as clinical professionals utilize genetic information to refine treatment plans.
This approach has led to improved outcomes for patients suffering from genetically-linked disorders. The emphasis on precision medicine is reshaping the healthcare landscape in India. Furthermore, the push for advanced research in genetic disorders is backed by both public and private sector initiatives, fueling the demand for innovative solutions tailored to the Indian populace.
Overall, the various facets of the Application segment are interconnected, each contributing to the broader objectives of enhancing healthcare practices and promoting individual well-being. As the India Human Genetics Market continues to evolve, these applications stand to play an essential role, underlining the growing significance of genetics in contemporary healthcare solutions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Test segment of the India Human Genetics Market encompasses a wide array of applications that are increasingly crucial in personalized medicine and genetic research. Notably, Non-Invasive Prenatal Testing (NIPT) has gained significant ground due to its safe and accurate assessment of genetic conditions in unborn children, making it a preferred choice for expectant parents.
Carrier Testing is also pivotal, as it enables individuals to understand their genetic risks for inheritable conditions, which is essential for family planning in the Indian context. Pharmacogenomic Testing offers insights into how an individual's genetic makeup affects their response to medications, thereby facilitating tailored treatment plans that improve efficacy and reduce adverse effects.
Karyotype Testing and Thrombophilia Testing play critical roles in diagnosing chromosomal abnormalities and understanding blood clotting disorders, respectively. Further, Septin 9 Biomarker Testing is significant in detecting colorectal cancer early, enhancing treatment outcomes in a country with rising cancer incidences.
Next-Generation Sequencing (NGS) serves as a cutting-edge technology that provides comprehensive genetic information, thus revolutionizing research and diagnostics in multiple areas.
With such diverse applications and a growing emphasis on early detection and precision medicine, the Test segment is set to experience substantial growth in India, driven by increasing awareness and the rising prevalence of genetic disorders.
India Human Genetics Market Key Players and Competitive Insights:
The India Human Genetics Market is witnessing notable growth and transformation, driven by advancements in genetic research and technology, increasing awareness among the population about genetic disorders, and the demand for personalized medicine.
The competitive landscape is characterized by a mix of established multinational corporations and emerging local players striving to enhance their market positions through innovation, partnerships, and strategic investments. The proliferation of genetic testing services, coupled with government initiatives promoting healthcare innovations, has further intensified competition among key stakeholders.
As a result, companies are innovating their product offerings and forming alliances, aiming to capture a larger share of a rapidly evolving market. Illumina has made a significant mark in the India Human Genetics Market with its innovative next-generation sequencing technologies.
Renowned for its strong research focus, Illumina has successfully established a robust market presence in India, targeting hospitals, research institutions, and laboratories.
The company is recognized for its pioneering work in genomic studies and personalized medicine, providing high-throughput sequencing platforms and comprehensive genomic solutions tailored for various applications including oncology, reproductive health, and infectious diseases.
Illumina’s strength lies in its strong brand reputation, commitment to advancing genomics, extensive distribution network, and established relationships with local research partners, all of which have positioned the company as a leader in the Indian genetic testing landscape.
Zydus Cadila operates prominently within the India Human Genetics Market, focusing on biopharmaceuticals and genetic testing services. As a major player, Zydus Cadila has developed key products that cater to several therapeutic areas, including genetic disorders and oncology.
The company’s strengths include its extensive research and development capabilities, a strong manufacturing base, and a comprehensive portfolio of genetic tests aimed at improving patient outcomes.
Zydus Cadila has also been active in pursuing mergers and acquisitions to bolster its capabilities and expand its offerings in the genomics space. This proactive approach to innovation and growth enhances its competitive edge in the market, allowing Zydus Cadila to maintain a resilient presence in the ever-evolving landscape of human genetics in India.
Key Companies in the India Human Genetics Market Include:
India Human Genetics Market Developments
The India Human Genetics Market has witnessed significant developments recently. Illumina has been advancing its genetic sequencing technologies, leading to a rise in applications within diagnostics and research.
In September 2023, Zydus Cadila announced a partnership with Novartis to enhance genetic therapies and personalized medicine approaches in India. Strand Life Sciences has reported expanding its genomic services, focusing on cancer genetics, which reflects the increasing demand for precision medicine in the country.
In October 2023, Biocon's collaboration with Genomic Health aims to develop novel biomarkers, enhancing diagnostics in oncology, while Thermo Fisher Scientific has emphasized growth in genetic testing, bolstered by the rising prevalence of genetic disorders in India. Furthermore, MedGenome recently engaged in discussions to acquire small genomic startups to expand its market footprint.
Market valuation is experiencing growth due to innovative products and increasing investments in genetic research, which impact healthcare delivery in India positively.
Notable events in the last few years include the rising prevalence of personal genomics services and significant investments in biotechnology infrastructure, contributing to the market's expansion in the nation. As a whole, these advancements underscore the dynamic nature of the human genetics sector in India.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.15(USD Billion) |
| MARKET SIZE 2024 | 1.27(USD Billion) |
| MARKET SIZE 2035 | 4.12(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.289% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Illumina, Zydus Cadila, Novartis, Strand Life Sciences, Biocon, Genomic Health, BristolMyers Squibb, Avesthagen, Thermo Fisher Scientific, Vinta Biosciences, Roche, Bharat Biotech, MedGenome, Merck KGaA, Qiagen |
| SEGMENTS COVERED | Application, Test |
| KEY MARKET OPPORTUNITIES | Growing demand for personalized medicine, Advancements in genetic testing technologies, Increasing prevalence of genetic disorders, Expansion of biotechnology investments, Rising awareness of genetic health risks |
| KEY MARKET DYNAMICS | Increasing genetic disorders prevalence, Rising awareness and education, Government support and funding, Advancements in genomic technologies, Growing healthcare expenditure |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Human Genetics Market is expected to be valued at 1.27 billion USD in 2024.
By 2035, the India Human Genetics Market is anticipated to reach a value of 4.12 billion USD.
The India Human Genetics Market is expected to grow at a CAGR of 11.289% from 2025 to 2035.
The Wellness & E-Commerce application segment is expected to grow to 1.25 billion USD by 2035.
The Diagnostic & Treatment application segment is expected to be valued at 0.57 billion USD in 2024.
The Preventive Medicine application segment is projected to reach 1.0 billion USD by 2035.
Key players in the market include Illumina, Zydus Cadila, Novartis, and Strand Life Sciences among others.
Companies like Illumina and Biocon are expected to significantly impact the growth of the market.
The market for the Wellness & E-Commerce application is expected to grow from 0.4 billion USD in 2024 to 1.25 billion USD by 2035.
The competition in the India Human Genetics Market is intense with multiple key players striving for market share.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
